☰

David Easterhoff, Ph.D. - Publications

Affiliations: 
2013 School of Medicine and Dentistry University of Rochester, Rochester, NY 
Area:
HIV-1, influenza A virus
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Williams LD, Shen X, Sawant SS, Akapirat S, Dahora LC, Tay MZ, Stanfield-Oakley S, Wills S, Goodman D, Tenney D, Spreng RL, Zhang L, Yates NL, Montefiori DC, Eller MA, ... Easterhoff D, et al. Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response. Plos Pathogens. 19: e1011359. PMID 37256916 DOI: 10.1371/journal.ppat.1011359  0.453
2021 Tolbert WD, Nguyen DN, Tuyishime M, Crowley AR, Chen Y, Jha S, Goodman D, Bekker V, Mudrak SV, DeVico AL, Lewis GK, Theis JF, Pinter A, Moody MA, Easterhoff D, et al. Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s. Frontiers in Immunology. 12: 787603. PMID 35069563 DOI: 10.3389/fimmu.2021.787603  0.385
2021 Pollara J, Tay MZ, Edwards RW, Goodman D, Crowley AR, Edwards RJ, Easterhoff D, Conley HE, Hoxie T, Gurley T, Jones C, Machiele E, Tuyishime M, Donahue E, Jha S, et al. Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques. Frontiers in Immunology. 12: 678511. PMID 34093580 DOI: 10.3389/fimmu.2021.678511  0.376
2021 Tolbert WD, Van V, Sherburn R, Tuyishime M, Yan F, Nguyen DN, Stanfield-Oakley S, Easterhoff D, Bonsignori M, Haynes BF, Moody MA, Ray K, Ferrari G, Lewis GK, Pazgier M. Erratum for Tolbert et al., "Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial". Mbio. 12. PMID 33824213 DOI: 10.1128/mBio.00474-21  0.34
2020 Tolbert WD, Van V, Sherburn R, Tuyishime M, Yan F, Nguyen DN, Stanfield-Oakley S, Easterhoff D, Bonsignori M, Haynes BF, Moody MA, Ray K, Ferrari G, Lewis GK, Pazgier M. Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial. Mbio. 11. PMID 32605979 DOI: 10.1128/Mbio.00208-20  0.496
2020 Easterhoff D, Pollara J, Luo K, Janus B, Gohain N, Williams LD, Tay MZ, Monroe A, Peachman K, Choe M, Min S, Lusso P, Zhang P, Go EP, Desaire H, et al. HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. Jci Insight. 5. PMID 31996483 DOI: 10.1172/Jci.Insight.131437  0.467
2019 Saunders KO, Wiehe K, Tian M, Acharya P, Bradley T, Alam SM, Go EP, Scearce R, Sutherland L, Henderson R, Hsu AL, Borgnia MJ, Chen H, Lu X, Wu NR, ... ... Easterhoff D, et al. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation. Science (New York, N.Y.). 366. PMID 31806786 DOI: 10.1126/Science.Aay7199  0.467
2019 Easterhoff D, Pollara J, Luo K, Tolbert WD, Young B, Mielke D, Jha S, O'Connell RJ, Vasan S, Kim J, Michael NL, Excler JL, Robb ML, Rerks-Ngarm S, Kaewkungwal J, et al. Boosting with AIDSVAX B/E enhances Env constant region 1 and 2 antibody-dependent cellular cytotoxicity breadth and potency. Journal of Virology. PMID 31776278 DOI: 10.1128/Jvi.01120-19  0.502
2018 Bonsignori M, Scott E, Wiehe K, Easterhoff D, Alam SM, Hwang KK, Cooper M, Xia SM, Zhang R, Montefiori DC, Henderson R, Nie X, Kelsoe G, Moody MA, Chen X, et al. Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier. Immunity. PMID 30552024 DOI: 10.1016/J.Immuni.2018.10.015  0.468
2018 Wiehe K, Bradley T, Meyerhoff RR, Hart C, Williams WB, Easterhoff D, Faison WJ, Kepler TB, Saunders KO, Alam SM, Bonsignori M, Haynes BF. Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development. Cell Host & Microbe. PMID 29861171 DOI: 10.1016/J.Chom.2018.04.018  0.362
2017 Easterhoff D, Moody MA, Fera D, Cheng H, Ackerman M, Wiehe K, Saunders KO, Pollara J, Vandergrift N, Parks R, Kim J, Michael NL, O'Connell RJ, Excler JL, Robb ML, et al. Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial. Plos Pathogens. 13: e1006182. PMID 28235027 DOI: 10.1371/Journal.Ppat.1006182  0.496
2017 Pollara J, Easterhoff D, Fouda GG. Lessons learned from human HIV vaccine trials. Current Opinion in Hiv and Aids. PMID 28230655 DOI: 10.1097/Coh.0000000000000362  0.453
2016 Luo K, Liao HX, Zhang R, Easterhoff D, Wiehe K, Gurley TC, Armand LC, Allen AA, Von Holle TA, Marshall DJ, Whitesides JF, Pritchett J, Foulger A, Hernandez G, Parks R, et al. Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques. Jci Insight. 1: e88522. PMID 27942585 DOI: 10.1172/Jci.Insight.88522  0.366
2016 Ding S, Verly MM, Princiotto A, Melillo B, Moody T, Bradley T, Easterhoff D, Roger M, Hahn BH, Madani N, Smith Iii AB, Haynes BF, Sodroski JG, Finzi A. Small Molecule CD4-Mimetics Sensitize HIV-1-infected Cells to ADCC by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Non-Human Primates. Aids Research and Human Retroviruses. PMID 27846736 DOI: 10.1089/Aid.2016.0246  0.55
2016 Madani N, Princiotto AM, Easterhoff D, Bradley T, Luo K, Williams WB, Liao HX, Moody MA, Phad GE, Bernat NV, Melillo B, Santra S, Smith AB, Karlsson Hedestam GB, Haynes B, et al. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds. Journal of Virology. PMID 26962221 DOI: 10.1128/Jvi.03211-15  0.472
2014 Wiehe K, Easterhoff D, Luo K, Nicely NI, Bradley T, Jaeger FH, Dennison SM, Zhang R, Lloyd KE, Stolarchuk C, Parks R, Sutherland LL, Scearce RM, Morris L, Kaewkungwal J, et al. Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved. Immunity. 41: 909-18. PMID 25526306 DOI: 10.1016/J.Immuni.2014.11.014  0.451
2014 Moody MA, Santra S, Vandergrift NA, Sutherland LL, Gurley TC, Drinker MS, Allen AA, Xia SM, Meyerhoff RR, Parks R, Lloyd KE, Easterhoff D, Alam SM, Liao HX, Ward BM, et al. Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. Journal of Virology. 88: 3329-39. PMID 24390332 DOI: 10.1128/Jvi.03309-13  0.408
2013 Easterhoff D, DiMaio JT, Liyanage W, Lo CW, Bae W, Doran TM, Smrcka A, Nilsson BL, Dewhurst S. Fluorescence detection of cationic amyloid fibrils in human semen. Bioorganic & Medicinal Chemistry Letters. 23: 5199-202. PMID 23910594 DOI: 10.1016/J.Bmcl.2013.06.097  0.478
2013 Easterhoff D, Ontiveros F, Brooks LR, Kim Y, Ross B, Silva JN, Olsen JS, Feng C, Hardy DJ, Dunman PM, Dewhurst S. Semen-derived enhancer of viral infection (SEVI) binds bacteria, enhances bacterial phagocytosis by macrophages, and can protect against vaginal infection by a sexually transmitted bacterial pathogen. Antimicrobial Agents and Chemotherapy. 57: 2443-50. PMID 23507280 DOI: 10.1128/Aac.02464-12  0.521
2013 Rojas AV, Easterhoff D, DiMaio JT, Dewhurst S, Grossfield A, Miao H, Nilsson BL. 147Characterizing the conformational space of two disordered peptides in different solutions Journal of Biomolecular Structure and Dynamics. 31: 95-95. DOI: 10.1080/07391102.2013.786389  0.519
2011 Olsen JS, Easterhoff D, Dewhurst S. Advances in HIV microbicide development. Future Medicinal Chemistry. 3: 2101-16. PMID 22098355 DOI: 10.4155/Fmc.11.153  0.553
2011 Easterhoff D, DiMaio JT, Doran TM, Dewhurst S, Nilsson BL. Enhancement of HIV-1 infectivity by simple, self-assembling modular peptides. Biophysical Journal. 100: 1325-34. PMID 21354406 DOI: 10.1016/J.Bpj.2011.01.037  0.583
Show low-probability matches.